Live Cell Imaging Market To Be Valued at US$ 2,921.9 Mn in 2028

Live Cell Imaging is a method to optically investigate living cells over a period of time using time-lapse microscopy. It is an analytical tool used in laboratories to study biomedical research disciplines, such as neurobiology, cell biology, pharmacology, & developmental biology. Live cell imaging techniques allow scientists to observe cell structures and processes in real time, and over time. Live Cell Imaging is used by scientists to obtain a better understanding of the biological function through the study of cellular dynamics. Furthermore, live cell imaging has revolutionized cell biology by facilitating cell structure and process observation in real time, and over time leading to better insight into the operations of a cell.

Market Statistics:

The global live cell imaging market is estimated to account for US$ 1,924.4 Mn in terms of value by the end of 2022.

Drivers:

Increase in funding for cell-based research by government and non-government organizations is expected to drive growth of the global live cell imaging market over the forecast period. For instance, in April 2022, Nanolive SA raised around US$ 20 million Series C-1 Round to drive significant growth of their digital assay solutions for live cell imaging and analysis. Nanolive is working closely with investors to secure a second close within ninety days. Nanolive is well-positioned to provide crucial tools and solutions to pharmaceutical and biotech companies and research institutes for developing better therapies that would save millions of patient lives.

Opportunities:

Increasing geriatric population worldwide is expected to offer significant growth opportunities for players in the global live cell imaging market. The growing aging population demands for intensive research in chronic diseases such as cancer, neurodegeneration, and cardiac diseases. Thus, with the increasing prevalence of chronic diseases, the usage of live cell imaging is also increasing rapidly. India's elderly population (aged 60 and above) is expected to reach around 194 million in 2031 from 138 million in 2021, a 41% increase over a decade, according to the National Statistical Office (NSO)'s Elderly in India 2021 report.

To know the latest trends and insights prevalent in the Live Cell Imaging Market, click the link below:

https://www.coherentmarketinsights.com/market-insight/live-cell-imaging-market-1081

Restraints:

High cost of high-content screening systems and dearth of skilled professionals are some major factors expected to hamper the growth of the global live cell imaging market. The maintenance costs and several other indirect expenses increase the total cost of these instruments. High cost, thus, hinders the wide adoption of high-content screening instruments in clinical and research applications. Furthermore, live cell imaging technology requires highly skilled professionals to understand and study the functions of cells. Therefore, the shortage of skilled professionals is likely to hinder growth of the market.

Global Live Cell Imaging Market - Impact of Coronavirus (Covid-19) Pandemic

The COVID-19 pandemic has resulted in a tremendous increase in the burden on healthcare organizations across the globe. According to WHO, worldwide, as of 4:41pm CEST, 19 August 2022, there have been 591,683,619 confirmed cases of COVID-19, including 6,443,306 deaths. Moreover, the outbreak of COVID-19 is changing how laboratories function. Live cell imaging is making research easier and adding efficiency to laboratories under COVID-19 restrictions. Furthermore, the increasing demand for the early diagnosis of COVID-19 infection in order to develop an effective vaccination propelled the growth of the live cell imaging market as it led to increasing usage of the live cell imaging process.

Key Takeaways:

The global live cell imaging market was valued at US$ 1,801.9 Mn in 2021 and is forecast to reach a value of US$ 2,921.9 Mn by 2028 at a CAGR of 7.2% between 2022 and 2028.

Among product, equipment segment held dominant position in the global live cell imaging market in 2021, accounting for 55.7% share in terms of value, increasing approval and launch of new products is expected to propel growth of the segment during the forecast period.

Market Trends:

1. Increasing prevalence of chronic diseases across the globe is expected to propel the growth of the global live cell imaging market. For instance, demand for live cell imaging is increasing due to the high incidence of chronic diseases and the corresponding need for rapid diagnostic techniques. As per the World Health Organization (WHO), chronic diseases, such as diabetes, cancer, and heart disease, are the leading causes of death and disability across the world.
2. Increasing adoption of live cell imaging techniques is expected to aid in the growth of the live cell imaging market. For instance, in May 2020, CytoSMART Technologies launched the new live-cell imaging system, named CytoSMART Lux2 Duo Kit. The CytoSMART Lux2 Duo Kit offers a straightforward, cost-effective solution for researchers carrying out immediate side-by-side comparisons between cell cultures.

Competitive Landscape:

Major players operating in the global live cell imaging market include Thermo Fisher Scientific Inc., Merck KgaA, PerkinElmer Inc., Nikon Instruments Inc., Live Cell Instrument, Olympus Corporation, Danaher Corporation, CytoSMART Technologies, ZEISS Group, and Becton, Dickinson and Company, among others.

Recent Developments:

In December 2021, Becton, Dickinson and Company announced the acquisition of Scanwell Health Inc., a privately held company engaged in smartphone-enabled at-home medical tests, for expansion of its presence in digital at-home testing offering.

In December 2020, CytoSMART Technologies announced the opening of CytoSMART Technologies LLC as its US subsidiary. This initiative aimed at addressing the growing demand for its automated live cell imaging technology.

In September 2021, Beckman Coulter launched DxU Iris Workcell, a fully automated system that streamlines urinalysis workflow by significantly minimizing sample processing time and reducing manual reviews.